Mycophenolate Mofetil for the Treatment of Primary Biliary Cirrhosis in Patients With an Incomplete Response to Ursodeoxycholic Acid

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Gastroenterology

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.mcg.0000150241.34382.d2PMID 15681915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate Mofetil

  2012cited by this paper
• Primary biliary cirrhosis.

  2003cited by this paper
• Rationale for trials of long‐term mycophenolate mofetil therapy for primary biliary cirrhosis

  2002cited by this paper
• Ten‐year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double‐blind, placebo‐controlled trial on symptomatic patients

  2001cited by this paper
• Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

  2000cited by this paper
• Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

  2000cited by this paper
• Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

  2000cited by this paper
• Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

  2000cited by this paper
• Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver.

  2000cited by this paper
• Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis.

  1999cited by this paper
• Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.

  1999cited by this paper
• Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.

  1999cited by this paper
• Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol.

  1999cited by this paper
• Primary biliary cirrhosis

  1998cited by this paper
• The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.

  1997cited by this paper
• Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

  1997cited by this paper
• A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.

  1996cited by this paper
• Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis.

  1996cited by this paper
• Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis.

  1996cited by this paper
• Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

  1995cited by this paper
• The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study

  1995cited by this paper
• The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

  1994cited by this paper
• Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.

  1994cited by this paper
• Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

  1994cited by this paper
• A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

  1993cited by this paper
• Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone.

  1993cited by this paper
• A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.

  1991cited by this paper
• Prognosis in primary biliary cirrhosis: Model for decision making

  1989cited by this paper
• One-sample multiple testing procedure for phase II clinical trials.

  1982cited by this paper

• The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects.

  2025cites this paper
• The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment

  2022cites this paper
• Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?

  2022cites this paper
• Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies.

  2022cites this paper
• Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis.

  2020cites this paper
• Risk factors for recurrent autoimmune liver diseases after liver transplantation

  2020cites this paper
• Emerging therapies for PBC

  2020cites this paper
• New Therapeutic Targets in Autoimmune Cholangiopathies

  2020cites this paper
• Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis

  2020cites this paper
• Review article: pathophysiology and management of primary biliary cholangitis

  2020cites this paper
• Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review

  2020cites this paper
• Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature.

  2019cites this paper
• Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.

  2019cites this paper
• Immunological abnormalities in patients with primary biliary cholangitis.

  2019cites this paper
• Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist☆

  2019cites this paper
• Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response

  2019cites this paper
• Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.

  2019cites this paper
• Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.

  2018cites this paper
• Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

  2018cites this paper
• Current Treatment Options for Primary Biliary Cholangitis.

  2018cites this paper
• Old and new treatments for primary biliary cholangitis

  2017cites this paper
• Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.

  2017cites this paper
• Treatment of primary biliary cholangitis ursodeoxycholic acid non‐responders: A systematic review

  2017cites this paper
• Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study

  2017cites this paper
• Update on pharmacotherapies for cholestatic liver disease

  2016cites this paper
• Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

  2015cites this paper
• ACG Clinical Guideline: Primary Sclerosing Cholangitis

  2015cites this paper
• Guidelines for the management of primary biliary cirrhosis

  2014cites this paper
• Cholestatic liver disease overlap syndromes.

  2013cites this paper
• Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid

  2013cites this paper
• Primary biliary cirrhosis: therapeutic advances.

  2013cites this paper
• Natural history and management of primary biliary cirrhosis

  2012cites this paper
• Current pharmacotherapy for cholestatic liver disease

  2012cites this paper
• Primary biliary cirrhosis and liver transplantation.

  2012cites this paper
• The Overlap Syndromes of Autoimmune Hepatitis

  2012cites this paper
• 原発性胆汁性肝硬変(PBC)の診療ガイドライン(2012年) : 厚生労働省難治性疾患克服研究事業「難治性の肝・胆道疾患に関する調査研究」班

  2012cites this paper
• The diagnosis and treatment of primary biliary cirrhosis

  2011cites this paper
• Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.

  2010cites this paper
• Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid

  2010cites this paper
• Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone.

  2010cites this paper
• Primary biliary cirrhosis

  2009cites this paper
• EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

  2009cites this paper
• Primary biliary cirrhosis

  2008cites this paper
• Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.

  2008cites this paper
• Medical treatment of cholestatic liver disease.

  2008cites this paper
• Clinical Use of Immunosuppressive Drugs to Control the Immune Response

  2007cites this paper
• Primary biliary cirrhosis and autoimmune cholangitis

  2007cites this paper
• Primary sclerosing cholangitis: Diagnosis and management

  2006cites this paper
• Concept on the pathogenesis and treatment of primary biliary cirrhosis.

  2006cites this paper
• Basic immunosuppressive drugs outside solid organ transplantation

  2006cites this paper
• Future Treatment Options in PBC.

  2005cites this paper
• medical progress Primary Biliary Cirrhosis

  2005cites this paper
• Primary biliary cirrhosis: Report of a focus study group

  2004cites this paper
• Primary biliary cirrhosis

  1998cites this paper
• Primary Biliary Cirrhosis

  1987cites this paper